Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 22;8(7):333.
doi: 10.3390/tropicalmed8070333.

Lymphatic Filariasis Elimination Status: Wuchereria bancrofti Infections in Human Populations after Five Effective Rounds of Mass Drug Administration in Zambia

Affiliations

Lymphatic Filariasis Elimination Status: Wuchereria bancrofti Infections in Human Populations after Five Effective Rounds of Mass Drug Administration in Zambia

Belem Blamwell Matapo et al. Trop Med Infect Dis. .

Abstract

Lymphatic filariasis (LF), also commonly known as elephantiasis, is a neglected tropical disease (NTD) caused by filarial parasites. The disease is transmitted via a bite from infected mosquitoes. The bites of these infected mosquitoes deposit filarial parasites, Wuchereria or Brugia, whose predilection site is the lymphatic system. The damage to the lymph system causes swelling in the legs, arms, and genitalia. A mapping survey conducted between 2003 and 2011 determined LF as being endemic in Zambia in 96 out of 116 districts. Elimination of LF is known to be possible by stopping the spread of the infection through large-scale preventive chemotherapy. Therefore, mass drug administration (MDA) with diethylcarbamazine citrate (DEC) (6 mg/kg) and Albendazole (400 mg) for Zambia has been conducted and implemented in all endemic districts with five effective rounds. In order to determine whether LF prevalence has been sufficiently reduced to levels less than 2% antigenemia and less than 1% microfilaremia, a pre-transmission assessment survey (pre-TAS) was conducted. Therefore, post-MDA pre-TAS was conducted between 2021 and 2022 in 80 districts to determine the LF prevalence. We conducted a cross-sectional seroprevalence study involving 600 participants in each evaluation unit (EU) or each district. The study sites (sentinel and spot-check sites) were from districts that were the implementation units (IUs) of the LF MDA. These included 80 districts from the 9 provinces. A total of 47,235 people from sentinel and spot-check locations were tested. Of these, valid tests were 47,052, of which 27,762 (59%) were females and 19,290 (41%) were males. The survey revealed in the 79/80 endemic districts a prevalence of Wb antigens of 0.14% and 0.0% prevalence of microfilariae. All the surveyed districts had an optimum prevalence of less than 2% for antigenaemia, except for Chibombo district. The majority of participants that tested positive for Wuchereria bancrofti (Wb) Antigens (Ag) were those that had 2, 3, and 4 rounds of MDA. Surprisingly, individuals that had 1 round of MDA were not found to have circulating antigens of Wb. The study showed that all the surveyed districts, except for Chibombo, passed pre-TAS. This further implies that there is a need to conduct transmission assessment surveys (TASs) in these districts.

Keywords: Zambia; antigenaemia; lymphatic filariasis; microfilariae; pre-TAS; prevalence.

PubMed Disclaimer

Conflict of interest statement

The authors declared no conflict of interest.

Figures

Figure 1
Figure 1
Lymphatic Filariasis Status of pre-TAS Implementation by District, Zambia, 2022.

References

    1. Coulibaly Y.I., Coulibaly S.Y., Dolo H., Konate S., Diallo A.A., Doumbia S.S., Soumaoro L., Coulibaly M.E., Dicko I., Sangare M.B., et al. Dynamics of antigenemia and transmission intensity of Wuchereria bancrofti following cessation of mass drug administration in a formerly highly endemic region of Mali. Parasites Vectors. 2016;9:628. doi: 10.1186/s13071-016-1911-9. - DOI - PMC - PubMed
    1. Dewi R.M., Tuti S., Ganefa S., Anwar C., Larasati R., Ariyanti E., Herjati H., Brady M. Brugia RapidTM antibody responses in communities of Indonesia in relation to the results of “transmission assessment surveys” (TAS) for the lymphatic filariasis elimination program. Parasites Vectors. 2015;8:499. doi: 10.1186/s13071-015-1093-x. - DOI - PMC - PubMed
    1. Nutman T.B. Insights into the pathogenesis of disease in human lymphatic filariasis. Lymphat. Res. Biol. 2013;11:144–148. doi: 10.1089/lrb.2013.0021. - DOI - PMC - PubMed
    1. Manguin S., Bangs M.J., Pothikasikorn J., Chareonviriyaphap T. Review on global co-transmission of human Plasmodium species and Wuchereria bancrofti by Anopheles mosquitoes. Infect. Genet. Evol. 2010;10:159–177. doi: 10.1016/j.meegid.2009.11.014. - DOI - PubMed
    1. Small S.T., Tisch D.J., Zimmerman P.A. Molecular epidemiology, phylogeny and evolution of the filarial nematode Wuchereria bancrofti. Infect. Genet. Evol. 2014;28:33–43. doi: 10.1016/j.meegid.2014.08.018. - DOI - PMC - PubMed